On demand webinar

Diagnosis and assessment of Metabolic Dysfunction-Associated Fatty Liver Disease: Exploring Australia’s first consensus statement for primary care

Members login for free access About RACGP online events

Details

Type: On-demand
Recorded: 24 Sep 2024

Contact

For more information:
Email: RACGP Specific Interests

Price

RACGP Members: Free
Non-Members: Free

Watch now

Diagnosis and assessment of Metabolic Dysfunction-Associated Fatty Liver Disease: Exploring Australia’s first consensus statement for primary care

On-demand recorded 24 Sep 2024

This GP-friendly webinar will provide an overview of the first Australian consensus statement for the diagnosis and assessment of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in primary care.

Presented by Prof Leon Adams (Co-Chair of the Gastroenterological Society of Australia MAFLD Consensus Statement Project) and Dr Gary Deed (Chair, RACGP Specific Interests Diabetes), this webinar will outline what the new evidence-based recommendations are and explore how you can apply them to a clinical pathway for your patients.

Learning outcomes

Outline the best-practice diagnosis and assessment of MAFLD and related comorbid conditions
Describe the clinical implications of the recommendations including referral and monitoring strategies

Create Quick log

Host

Dr Gary Deed
Chair, RACGP Specific Interests Diabetes

Dr Gary Deed is a general practitioner based in Carindale Brisbane, with a passionate interest in promoting quality patient care of diabetes in general practice through education, development of resources including guidelines, policy development, research and strategic collaboration. He is the Chair of RACGP Specific Interests Diabetes and a member of the RACGP Quality Care committee, and involved in RACGP resource development in diabetes, education, and policy.

Presenter

Professor Leon Adams
MBBS, FRACP, PhD

Dr Leon Adams (MBBS, FRACP, PhD) is a Consultant Hepatologist at Sir Charles Gairdner Hospital and Professor in the Medical School, University of Western Australia. His research interests focus on MAFLD and non-invasive assessment of liver disease. He is chair of the GESA consensus steering committee for the assessment of fatty liver disease in primary care, and has served on numerous journal editorial boards, faculties and committees within GESA, the Australian Diabetes Society, Cancer Council Australia, the American Gastroenterology Association and American Association for the Study of Liver Disease.

Presented by

Disclaimer

The RACGP reserves the right and has sole discretion for any reason and at any time to:

Change the date, location, format, timing and/or any other aspect of an event;
Postpone Events in full or any part of those Events; and/or
Cancel an Event in full or any part. Should this occur, RACGP will issue a notification of change via our website, social media and/or electronic communications. Unless specifically permitted by RACGP’s Delegate Terms and Conditions, RACGP will not be liable for any damages, costs, losses or expenses of any kind incurred or suffered in connection with the RACGP modifying, postponing or cancelling an Event or any part. Please refer to our Delegate Terms and Conditions for further information

Advertising